AU1189301A - A pharmaceutical composition having high cell membrane permeability - Google Patents

A pharmaceutical composition having high cell membrane permeability

Info

Publication number
AU1189301A
AU1189301A AU11893/01A AU1189301A AU1189301A AU 1189301 A AU1189301 A AU 1189301A AU 11893/01 A AU11893/01 A AU 11893/01A AU 1189301 A AU1189301 A AU 1189301A AU 1189301 A AU1189301 A AU 1189301A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
cell membrane
high cell
membrane permeability
permeability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11893/01A
Inventor
Michael Terrence Kuhfeld
Ovidio Vargas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1189301A publication Critical patent/AU1189301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU11893/01A 1999-10-29 2000-10-16 A pharmaceutical composition having high cell membrane permeability Abandoned AU1189301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16255799P 1999-10-29 1999-10-29
US60162557 1999-10-29
PCT/US2000/026257 WO2001032201A2 (en) 1999-10-29 2000-10-16 A pharmaceutical composition having high cell membrane permeability

Publications (1)

Publication Number Publication Date
AU1189301A true AU1189301A (en) 2001-05-14

Family

ID=22586144

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11893/01A Abandoned AU1189301A (en) 1999-10-29 2000-10-16 A pharmaceutical composition having high cell membrane permeability

Country Status (3)

Country Link
AU (1) AU1189301A (en)
PE (1) PE20010825A1 (en)
WO (1) WO2001032201A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158777A0 (en) 2001-06-01 2004-05-12 Novartis Ag Orally administering parathyroid hormone and calcitonin
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN118001411A (en) * 2024-04-09 2024-05-10 深圳奥礼生物科技有限公司 Intestinal tract absorption composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
JPH11292787A (en) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd Transucosal preparation containing physiologically active peptide
DE19538687A1 (en) * 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stable pharmaceutical dosage forms containing parathyroid hormone

Also Published As

Publication number Publication date
WO2001032201A3 (en) 2001-09-27
WO2001032201A2 (en) 2001-05-10
PE20010825A1 (en) 2001-08-13

Similar Documents

Publication Publication Date Title
AU4451600A (en) Oriented biopolymeric membrane
AU2205701A (en) Rotating membrane
AU6864600A (en) Fuel cell
AU3793301A (en) High differential pressure electrochemical cell
AU6906800A (en) Membrane associated proteins
AU4993200A (en) Fuel cell and membrane
AU2001286207A1 (en) Porous membrane
AUPQ223499A0 (en) Fuel cell system
AU2001238359A1 (en) Membranes
AU5003600A (en) Charged membrane
AU2001270819A1 (en) Polymer electrolyte
AU2619100A (en) Roll roofing membrane
AU2001292317A1 (en) Fuel cell
EP1119065A3 (en) Fuel cell system
AU6906200A (en) Fuel cell system
AUPQ002399A0 (en) Model membrane systems
AU2001294342A1 (en) Porous attachment material for cells
AU2203901A (en) Microporous membrane
AU2002221371A1 (en) Cathodic protection system utilizing a membrane
AU2001267724A1 (en) Electrochemical cell
AU6179400A (en) Multi-photodetector unit cell
AU4081900A (en) Porous membrane
AU4391900A (en) Electrochemical cell
AU2001264066A1 (en) A cell incorporating a porous membrane
AU1189301A (en) A pharmaceutical composition having high cell membrane permeability

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase